Abstract
With patients demanding a greater role in the clinical decision-making process, many researchers are developing and disseminating decision aids for various medical conditions. In this article, we outline the essential elements in the development and evaluation of a decision aid to help patients with atrial fibrillation choose, in consultation with their physicians, appropriate antithrombotic therapy (warfarin, aspirin, or no therapy) to prevent stroke. We also outline possible future directions regarding the implementation and evaluation of this decision aid. This information should enable clinicians to better understand the role that decision aids may have in their interactions with patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 723-730 |
| Number of pages | 8 |
| Journal | Journal of general internal medicine |
| Volume | 15 |
| Issue number | 10 |
| DOIs | |
| State | Published - 2000 |
Bibliographical note
Funding Information:This study was supported by grants from the Medical Research Council of Canada, the National Institute of Neurological Disorders and Stroke (RO1 NS 24224), Bethesda, Md, and DuPont Pharma.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aspirin
- Atrial fibrillation
- Decision aid
- Warfarin
Fingerprint
Dive into the research topics of 'Development of a decision aid for patients with atrial fibrillation who are considering antithrombotic therapy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS